Issues in Developing Drugs for Primary Brain Tumors: Barriers and Toxicities
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Issues in Developing Drugs for Primary Brain Tumors: Barriers and Toxicities
Authors
Keywords
-
Journal
TOXICOLOGIC PATHOLOGY
Volume 39, Issue 1, Pages 152-157
Publisher
SAGE Publications
Online
2010-12-09
DOI
10.1177/0192623310391482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interim data for ACT III: Phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM).
- (2017) R. Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
- (2010) S. Kunwar et al. NEURO-ONCOLOGY
- The Neuropharmacokinetics of Temozolomide in Patients with Resectable Brain Tumors: Potential Implications for the Current Approach to Chemoradiation
- (2009) J. Portnow et al. CLINICAL CANCER RESEARCH
- Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients
- (2009) C. Nieder et al. CLINICAL ONCOLOGY
- A Network Model of a Cooperative Genetic Landscape in Brain Tumors
- (2009) Markus Bredel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status
- (2009) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffusion Magnetic Resonance Imaging Detects Pathologically Confirmed, Nonenhancing Tumor Progression in a Patient With Recurrent Glioblastoma Receiving Bevacizumab
- (2009) Elizabeth R. Gerstner et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing
- (2008) Jason T. Huse et al. BRAIN PATHOLOGY
- Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience
- (2008) Michael Sabel et al. CURRENT MEDICAL RESEARCH AND OPINION
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started